Skip to main content
Clinical Trials/PACTR202104706858270
PACTR202104706858270
Completed
Phase 4

Effects of moderate-intensity aerobic exercise training on cardiorespiratory parameters among stroke survivors: A randomized controlled trial comparing cycling ergometer with treadmill

asir Hassan0 sites45 target enrollmentMarch 18, 2021
ConditionsRespiratory

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Respiratory
Sponsor
asir Hassan
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 18, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
asir Hassan

Eligibility Criteria

Inclusion Criteria

  • 1\. Male ambulatory hemiplegic stroke patients aged between 18 to 65 years old.
  • 2\. Ambulatory male hemiplegic stroke patient capable for 6 minutes walk test.
  • 3\.Stroke patient with at least Brunnstrom Recovery Stage (BRM) 3 on the lower limb and Modified Asworth Scale between stage \+1 to 3
  • 4\.Male ambulatory hemiplegic stroke patients willing to participate for the study.
  • 5\.Male ambulatory hemiplegic stroke patients who are psychologically oriented

Exclusion Criteria

  • 1\.Female Stroke patient
  • 2\. male stroke patient below the age of 18 and above 65 years of age
  • 3\.Presence of red flags (History of cancer, malaise, weight loss, recent infection, bladder and/or bowel dysfunction).
  • 4\.Stroke patient with absolute contraindications for cardiopulmonary exercise testing according to American Thoracic Society (ATS) /American College of Chest Physicians (ACCP) criteria such as Unstable angina, aortic stenosis, uncontrolled hypertension, uncontrolled asthma, febrile illness,
  • 5\.Stroke patient with relative contraindications for cardiopulmonary exercise testing according to ATS /ACCP criteria such as cardiac disease, epilepsy, locomotors disorder
  • 6\.Male stroke patient with orthopedic conditions such as Limb Length Discrepancy, Fracture, or severe Osteoarthritis knee,

Outcomes

Primary Outcomes

Not specified

Similar Trials